Immune Predispositions for Cytomegalovirus Retinitis in AIDS. The HNRC Group
Overview
Authors
Affiliations
CMV retinitis develops in approximately 28-35% of all AIDS patients at later stages of disease, often leading to blindness. To determine whether the subset of AIDS patients who developed CMV retinitis (CMV-R) were immunologically predisposed, T cell proliferation responses to CMV were examined prospectively in an HIV infected, HLA typed, longitudinal study population. Individuals who developed CMV-R had significantly lower T cell proliferation responses to CMV, both early and late in disease, compared to CD4 matched controls who have not developed CMV-R. Since HLA proteins influence T-cell recognition, phenotypes of 21 CMV-R patients were examined to determine whether certain HLA alleles were associated with low immune response and predisposed AIDS patients to CMV-R. HLA DR7 and B44 were at increased (nearly twice the expected) frequency in those with CMV-R. The combined association of either B44, 51 or DR7 with CMV-R was highly significant (P = .008, relative risk of CMV-R = 15) with correction for multiple comparisons. Low immune responses were twice as frequent in those with (61%) compared to those without (30%) predisposing alleles. Thus, AIDS patients with immunogenetically related hyporesponsiveness to CMV antigens may be at increased risk of retinitis.
Narvaneni S, Tagliaferri A, Reid R, Horani G, Maroules M Cureus. 2021; 13(10):e18550.
PMID: 34754694 PMC: 8570985. DOI: 10.7759/cureus.18550.
Toomey C, Gross A, Lee J, Spencer D Case Rep Ophthalmol Med. 2019; 2019:1475628.
PMID: 31687242 PMC: 6800899. DOI: 10.1155/2019/1475628.
Antoine P, Varner V, Carville A, Connole M, Marchant A, Kaur A J Infect Dis. 2014; 210(7):1090-9.
PMID: 24719473 PMC: 4215082. DOI: 10.1093/infdis/jiu215.
Alonso Arias R, Moro-Garcia M, Echeverria A, Solano-Jaurrieta J, Suarez-Garcia F, Lopez-Larrea C J Virol. 2013; 87(8):4486-95.
PMID: 23388717 PMC: 3624366. DOI: 10.1128/JVI.02425-12.
Weinberg A, Spritzler J, Nokta M, Schrier R, Landay A, Brown D Clin Vaccine Immunol. 2008; 15(9):1398-409.
PMID: 18579698 PMC: 2546686. DOI: 10.1128/CVI.00479-07.